4//SEC Filing
Meltz Mark A 4
Accession 0001209191-19-060729
CIK 0001628738other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 6:04 PM ET
Size
5.4 KB
Accession
0001209191-19-060729
Insider Transaction Report
Form 4
Meltz Mark A
SVP, General Counsel
Transactions
- Tax Payment
Common Stock
2019-12-12$59.37/sh−4,628$274,764→ 32,705 total
Footnotes (2)
- [F1]On December 10, 2019, the Compensation Committee of the Issuer's Board of Directors approved the accelerated vesting and settlement of restricted stock units granted on March 28, 2019 in order to mitigate the potential adverse tax consequences of Sections 280G and 4999 of the Internal Revenue Code of 1986, as amended.
- [F2]Shares relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units. The Reporting Person did not sell or otherwise dispose of the shares for any reason other than to cover required taxes.
Documents
Issuer
Audentes Therapeutics, Inc.
CIK 0001628738
Entity typeother
Related Parties
1- filerCIK 0001771329
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 6:04 PM ET
- Size
- 5.4 KB